News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- STAT Plus: Pharmalittle: More clinical trials derailed by Covid-19; Pfizer jumpstarts tests on a drug to fight the pandemic
- EuroBiotech Report—AZ, GSK in COVID-19, $8B funding call, CRUK cuts and Evotec
- Mylan prepares hydroxychloroquine giveaways after production ramp-up
- EuroBiotech: More Articles of Note
- Qiming raises $1B fund, continuing big burst of VC activity
- Gilead supersizes remdesivir trials, changes primary endpoint
- Pfizer finds COVID-19 drug candidate, plots summer testing
- Pfizer says coronavirus drug could enter testing by fall
- How a Seattle Genetics cancer drug could help lupus patients with kidney damage
- STAT Plus: Biotech venture capital had a record-breaking quarter, but isn’t out of the woods yet
- Opinion: Learning about epidemic response from sub-Saharan African countries
- Opinion: A proper tribute to health care workers on the Covid-19 front lines: forgive their student loan debt
- You need a special lab to study the coronavirus. Here’s what it takes to get one up and running
- Opinion: I am far more than ‘just a nurse’
- With diving gear and plumbing supplies, California labs fashion Covid-19 masks and ventilators